BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 8542585)

  • 1. Altered cJUN expression: an early event in human lung carcinogenesis.
    Szabo E; Riffe ME; Steinberg SM; Birrer MJ; Linnoila RI
    Cancer Res; 1996 Jan; 56(2):305-15. PubMed ID: 8542585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression patterns of immediate early transcription factors in human non-small cell lung cancer. The Lung Cancer Study Group.
    Levin WJ; Press MF; Gaynor RB; Sukhatme VP; Boone TC; Reissmann PT; Figlin RA; Holmes EC; Souza LM; Slamon DJ
    Oncogene; 1995 Oct; 11(7):1261-9. PubMed ID: 7478546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation and inhibition of the AP-1 complex in human breast cancer cells.
    Chen TK; Smith LM; Gebhardt DK; Birrer MJ; Brown PH
    Mol Carcinog; 1996 Mar; 15(3):215-26. PubMed ID: 8597534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transition from SCLC to NSCLC phenotype is accompanied by an increased TRE-binding activity and recruitment of specific AP-1 proteins.
    Risse-Hackl G; Adamkiewicz J; Wimmel A; Schuermann M
    Oncogene; 1998 Jun; 16(23):3057-68. PubMed ID: 9662339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P-glycoprotein associated expression of c-fos and c-jun products in human lung carcinomas.
    Volm M
    Anticancer Res; 1993; 13(2):375-8. PubMed ID: 8100127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific members of the Jun protein family regulate collagenase expression in response to various extracellular stimuli.
    Angel P; Karin M
    Matrix Suppl; 1992; 1():156-64. PubMed ID: 1336108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between successful heterotransplantation of lung tumors in nude mice, poor prognosis of patients and expression of Fos, Jun, ErbB1, and Ras.
    Volm M; Mattern J
    Anticancer Res; 1993; 13(6A):2021-5. PubMed ID: 8297109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential induction of early response genes by adrenomedullin and transforming growth factor-beta1 in human lung cancer cells.
    Kane S; Prentice MA; Mariano JM; Cuttitta F; Jakowlew SB
    Anticancer Res; 2002; 22(3):1433-44. PubMed ID: 12168820
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels.
    Gruebele A; Zawaski K; Kaplan D; Novak RF
    Drug Metab Dispos; 1996 Jan; 24(1):15-22. PubMed ID: 8825185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of dominant negative Jun inhibits elevated AP-1 and NF-kappaB transactivation and suppresses anchorage independent growth of HPV immortalized human keratinocytes.
    Li JJ; Rhim JS; Schlegel R; Vousden KH; Colburn NH
    Oncogene; 1998 May; 16(21):2711-21. PubMed ID: 9652737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of oligonucleotide and tissue microarrays identifies cancer/testis antigens as biomarkers in lung carcinoma.
    Sugita M; Geraci M; Gao B; Powell RL; Hirsch FR; Johnson G; Lapadat R; Gabrielson E; Bremnes R; Bunn PA; Franklin WA
    Cancer Res; 2002 Jul; 62(14):3971-9. PubMed ID: 12124329
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neutral endopeptidase: variable expression in human lung, inactivation in lung cancer, and modulation of peptide-induced calcium flux.
    Cohen AJ; Bunn PA; Franklin W; Magill-Solc C; Hartmann C; Helfrich B; Gilman L; Folkvord J; Helm K; Miller YE
    Cancer Res; 1996 Feb; 56(4):831-9. PubMed ID: 8631021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Krüppel-like factor 6 is frequently down-regulated and induces apoptosis in non-small cell lung cancer cells.
    Ito G; Uchiyama M; Kondo M; Mori S; Usami N; Maeda O; Kawabe T; Hasegawa Y; Shimokata K; Sekido Y
    Cancer Res; 2004 Jun; 64(11):3838-43. PubMed ID: 15172991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered regulation of c-jun and its involvement in anchorage-independent growth of human lung cancers.
    Maeno K; Masuda A; Yanagisawa K; Konishi H; Osada H; Saito T; Ueda R; Takahashi T
    Oncogene; 2006 Jan; 25(2):271-7. PubMed ID: 16158054
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 7/interleukin 7 receptor induce c-Fos/c-Jun-dependent vascular endothelial growth factor-D up-regulation: a mechanism of lymphangiogenesis in lung cancer.
    Ming J; Zhang Q; Qiu X; Wang E
    Eur J Cancer; 2009 Mar; 45(5):866-73. PubMed ID: 19136250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targets.
    Leaner VD; Kinoshita I; Birrer MJ
    Oncogene; 2003 Aug; 22(36):5619-29. PubMed ID: 12944910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deregulated expression of c-mos in non-small cell lung carcinomas: relationship with p53 status, genomic instability, and tumor kinetics.
    Gorgoulis VG; Zacharatos P; Mariatos G; Liloglou T; Kokotas S; Kastrinakis N; Kotsinas A; Athanasiou A; Foukas P; Zoumpourlis V; Kletsas D; Ikonomopoulos J; Asimacopoulos PJ; Kittas C; Field JK
    Cancer Res; 2001 Jan; 61(2):538-49. PubMed ID: 11212247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of CXCR4 is associated with the metastatic potential of human non-small cell lung cancer cells.
    Su L; Zhang J; Xu H; Wang Y; Chu Y; Liu R; Xiong S
    Clin Cancer Res; 2005 Dec; 11(23):8273-80. PubMed ID: 16322285
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ANLN plays a critical role in human lung carcinogenesis through the activation of RHOA and by involvement in the phosphoinositide 3-kinase/AKT pathway.
    Suzuki C; Daigo Y; Ishikawa N; Kato T; Hayama S; Ito T; Tsuchiya E; Nakamura Y
    Cancer Res; 2005 Dec; 65(24):11314-25. PubMed ID: 16357138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.